Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5594294 | American Heart Journal | 2017 | 11 Pages |
Abstract
The BIOFLOW V trial offers an opportunity to assess clinical outcomes in patients treated with coronary revascularization using the Orsiro BP SES relative to a commonly used DP EES. The use of a Bayesian analysis combines a large randomized cohort of patients 2 two smaller contributing randomized trials to augment the efficiency of the comparison.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gheorghe PhD, Joseph M. PhD, David E. MD, Ron MD, Jacques J. MD, Donald E. MD, Laura MD, MSC,